Diagnosis and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

Stephanie L Grach1, Jaime Seltzer2, Tony Y Chon1

  • 1Division of General Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, MN.

Mayo Clinic Proceedings
|October 4, 2023
PubMed

Insights

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex neurologic illness. This review offers a generalist approach to diagnosing, evaluating, and managing ME/CFS, highlighting its overlap with long COVID.

Area of Science:

  • Neurology
  • Infectious Disease
  • Immunology

Background:

  • Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating neurologic illness often triggered by infection.
  • Recent research indicates substantial overlap between ME/CFS and post-COVID conditions (long COVID).
  • Estimates suggest up to 50% of long COVID patients meet ME/CFS diagnostic criteria.

Purpose of the Study:

  • To provide a concise overview of ME/CFS for a generalist audience.
  • To outline current diagnostic and evaluation strategies for ME/CFS.
  • To describe management approaches for patients with ME/CFS.

Main Methods:

  • Literature review of existing studies on ME/CFS and long COVID.
  • Synthesis of diagnostic criteria and clinical evaluation guidelines.
  • Summary of evidence-based management strategies.

Main Results:

  • ME/CFS diagnosis requires careful evaluation of characteristic symptoms.
  • Overlap with long COVID necessitates awareness and tailored management.
  • A multi-faceted approach is crucial for effective ME/CFS patient care.

Conclusions:

  • A generalist approach can facilitate ME/CFS diagnosis and management.
  • Recognizing the ME/CFS and long COVID connection is vital for clinical practice.
  • Further research is needed to elucidate the pathophysiology and optimize treatments for ME/CFS.

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
937
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
99